POLIVY

Google image searchProduct monograph

Active ingredient

polatuzumab vedotin, 140 MG/VIAL

DIN: 02499614

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 25-NOV-2020

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
• L01FX14 — POLATUZUMAB VEDOTIN (ATC/DDD)

Pharmaceutical standard: PH EUR

External Links for Polivy

Search on Google

• Polivy side effects
• Polivy dosage
• polatuzumab vedotin side effects
• polatuzumab vedotin dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find polivy photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.